Displaying 1 to 20 of 152 investments
Country Date Notes
7TM Pharma A/S
Denmark N/A
Active
Ablynx NV
Belgium N/A
Active
Acelrx Pharmaceuticals Inc
Specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain.
United States N/A
Active
Achaogen Inc
Develops solutions to the problem of drug resistance
United States N/A
Initial investment. Round participant. Active
Aclara Biosciences Inc
Develops and distributes assay solutions for drug discovery and development
United States N/A
Active
Adolor Corp
United States N/A
Aegerion Pharmaceuticals Inc
United States N/A
Active
Aegis Lightwave Inc
United States 1 Mar 2006 Series D
Active
Aerie Pharmaceuticals Inc
United States 1 Mar 2011 Series B
Active
Aerovance Inc
United States 1 Mar 2007 Series C
Initial investment. Round participant. Active
Aerovance Inc
United States 1 Apr 2009 N/A
Active
AFx Inc
United States N/A
Agami Systems Inc
United States 21 Nov 2007 Series C
Initial investment. Round participant. Active
Agensys Inc
United States N/A
Active
Alba Therapeutics Corp
United States N/A
Active
Angiosyn Inc
United States N/A
Arete Therapeutics Inc
A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases.
United States 1 Nov 2008 Series A
Arrow Therapeutics Ltd
United Kingdom N/A
Astex Pharmaceuticals Inc
Drug discovery, development and commercialization.
United States N/A
Astex Therapeutics Ltd
United Kingdom N/A